Changes in symptoms of anxiety, depression, and PTSD in an RCT-study of dentist-administered treatment of dental anxiety.
Anxiety
CBT
Communication
Dental anxiety
Depression
Midazolam
PTSD
Sedation
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
22 06 2023
22 06 2023
Historique:
received:
07
01
2023
accepted:
19
05
2023
medline:
26
6
2023
pubmed:
23
6
2023
entrez:
22
6
2023
Statut:
epublish
Résumé
Educating dentists in treatment methods for dental anxiety would increase the patients' access to treatments that are important to their oral health. However, to avoid adverse effects on comorbid symptoms, involvement by a psychologist has been considered necessary. The objective of the present paper was to evaluate whether a dentist could implement systematized treatments for dental anxiety without an increase in comorbid symptoms of anxiety, depression or PTSD. A two-arm parallel randomised controlled trial was set in a general dental practice. Eighty-two patients with self-reported dental anxiety either completed treatment with dentist-administered cognitive behavioural therapy (D-CBT, n = 36), or received dental treatment while sedated with midazolam combined with the systemized communication technique "The Four Habits Model" (Four Habits/midazolam, n = 41). Dental anxiety and comorbid symptoms were measured pre-treatment (n = 96), post-treatment (n = 77) and one-year after treatment (n = 52). An Intention-To-Treat analysis indicated reduced dental anxiety scores by the Modified Dental Anxiety Scale (median MDAS: 5.0 (-1,16)). The median scores on the Hospital Index of Anxiety and Depression (HADS-A/D) and the PTSD checklist for DSM-IV (PCL) were reduced as follows: HADS-A: 1 (-11, 11)/HADS-D: 0 (-7, 10)/PCL: 1 (-17,37). No between-group differences were found. The study findings support that a general dental practitioner may treat dental anxiety with Four Habits/Midazolam or D-CBT without causing adverse effects on symptoms of anxiety, depression or PTSD. Establishing a best practice for treatment of patients with dental anxiety in general dental practice should be a shared ambition for clinicians, researchers, and educators. The trial was approved by REC (Norwegian regional committee for medical and health research ethics) with ID number 2017/97 in March 2017, and it is registered in clinicaltrials.gov 26/09/2017 with identifier: NCT03293342.
Sections du résumé
BACKGROUND
Educating dentists in treatment methods for dental anxiety would increase the patients' access to treatments that are important to their oral health. However, to avoid adverse effects on comorbid symptoms, involvement by a psychologist has been considered necessary. The objective of the present paper was to evaluate whether a dentist could implement systematized treatments for dental anxiety without an increase in comorbid symptoms of anxiety, depression or PTSD.
METHODS
A two-arm parallel randomised controlled trial was set in a general dental practice. Eighty-two patients with self-reported dental anxiety either completed treatment with dentist-administered cognitive behavioural therapy (D-CBT, n = 36), or received dental treatment while sedated with midazolam combined with the systemized communication technique "The Four Habits Model" (Four Habits/midazolam, n = 41). Dental anxiety and comorbid symptoms were measured pre-treatment (n = 96), post-treatment (n = 77) and one-year after treatment (n = 52).
RESULTS
An Intention-To-Treat analysis indicated reduced dental anxiety scores by the Modified Dental Anxiety Scale (median MDAS: 5.0 (-1,16)). The median scores on the Hospital Index of Anxiety and Depression (HADS-A/D) and the PTSD checklist for DSM-IV (PCL) were reduced as follows: HADS-A: 1 (-11, 11)/HADS-D: 0 (-7, 10)/PCL: 1 (-17,37). No between-group differences were found.
CONCLUSIONS
The study findings support that a general dental practitioner may treat dental anxiety with Four Habits/Midazolam or D-CBT without causing adverse effects on symptoms of anxiety, depression or PTSD. Establishing a best practice for treatment of patients with dental anxiety in general dental practice should be a shared ambition for clinicians, researchers, and educators.
TRIAL REGISTRATION
The trial was approved by REC (Norwegian regional committee for medical and health research ethics) with ID number 2017/97 in March 2017, and it is registered in clinicaltrials.gov 26/09/2017 with identifier: NCT03293342.
Identifiants
pubmed: 37349747
doi: 10.1186/s12903-023-03061-4
pii: 10.1186/s12903-023-03061-4
pmc: PMC10288821
doi:
Substances chimiques
Midazolam
R60L0SM5BC
Banques de données
ClinicalTrials.gov
['NCT03293342']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
415Informations de copyright
© 2023. The Author(s).
Références
Chest. 2011 Jul;140(1):16-18
pubmed: 21729890
Acta Odontol Scand. 1998 Apr;56(2):105-9
pubmed: 9669462
J Public Health Dent. 2015 Winter;75(1):64-73
pubmed: 25234823
Acta Odontol Scand. 2001 Dec;59(6):335-40
pubmed: 11831481
Eur J Dent Educ. 2019 Nov;23(4):515-521
pubmed: 31429501
J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
Int Dent J. 2020 Sep 14;:
pubmed: 32929752
Behav Modif. 2000 Sep;24(4):580-99
pubmed: 10992613
J Esthet Restor Dent. 2022 Jan;34(1):104-116
pubmed: 34953109
J Med Pract Manage. 2001 Jan-Feb;16(4):184-91
pubmed: 11317576
J Behav Ther Exp Psychiatry. 2008 Sep;39(3):381-90
pubmed: 18005932
Eur J Oral Sci. 2021 Dec;129(6):e12820
pubmed: 34448277
Community Dent Oral Epidemiol. 2004 Aug;32(4):250-64
pubmed: 15239776
Spec Care Dentist. 1993 Jul-Aug;13(4):139-42
pubmed: 8303507
Br J Oral Maxillofac Surg. 2000 Dec;38(6):612-616
pubmed: 11092778
Community Dent Health. 1995 Sep;12(3):143-50
pubmed: 7584581
Patient Educ Couns. 2004 Oct;55(1):149-52
pubmed: 15540370
Scand J Dent Res. 1990 Feb;98(1):53-9
pubmed: 1970194
Eur J Oral Sci. 2019 Dec;127(6):539-546
pubmed: 31731327
J Dent Educ. 2001 Dec;65(12):1357-68
pubmed: 11780654
Behav Res Ther. 2008 Dec;46(12):1305-10
pubmed: 18954863
Eur J Oral Sci. 2002 Apr;110(2):69-74
pubmed: 12013565
J Couns Psychol. 2022 Mar;69(2):235-245
pubmed: 34292029
Quintessence Int. 2021;0(0):360-373
pubmed: 33491392
J Dent. 2021 May;108:103632
pubmed: 33711405
Psychol Assess. 2010 Jun;22(2):279-87
pubmed: 20528055
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Eur J Oral Sci. 2022 Aug;130(4):e12872
pubmed: 35569119
Eur J Oral Sci. 2013 Jun;121(3 Pt 2):283-91
pubmed: 23659263
J Behav Ther Exp Psychiatry. 1991 Dec;22(4):243-53
pubmed: 1823658
Eur J Oral Sci. 2021 Aug;129(4):e12794
pubmed: 33960536
Clin Pract Epidemiol Ment Health. 2018 Aug 31;14:207-222
pubmed: 30288171
Dent J (Basel). 2020 Oct 13;8(4):
pubmed: 33066178
Community Dent Oral Epidemiol. 2017 Aug;45(4):330-336
pubmed: 28295476
Br Dent J. 2015 Nov 27;219(10):501-6; discussion 506
pubmed: 26611310
Behav Res Ther. 2002 Sep;40(9):1017-29
pubmed: 12296487
Acta Odontol Scand. 2001 Oct;59(5):290-6
pubmed: 11680648